Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06412198
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-05-09
Brief Title:
A Multicenter Phase 1b2 Study of Adagrasib Cetuximab and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-30
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-09
First Submit QC Date:
May 9 2024
Study First Post Date:
2024-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-05
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL